(Q44968633)

English

Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.

scientific article published on 29 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Kathrin Sebelin-Wulf

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Tuan D Nguyen

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Stephan Oertel

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Matthias Papp-Vary

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Antje Schulzki

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Antonio Pezzutto

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Hanno Riess

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Marion Subklewe

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Transplant Immunology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

203-210

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Donor T cells to treat EBV-associated lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Malignancy after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.1

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Tracking T cells with tetramers: new tales from new tools

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.10.006

7 January 2021

Identifiers

10.1016/J.TRIM.2006.10.006

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44968633&oldid=1621431226"